New York, United States, March 15, 2024 (GLOBE NEWSWIRE) -- The Global Self Injection Device Market Size is to Grow from USD 6.5 Billion in 2023 to USD 10.7 Billion ...

Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Self-injection Devices Market by Product, Usability, Application, Distribution Channel, and Region" report has been added to ResearchAndMarkets.com's ...

Explore what clinical research actually says about dermal fillers, dispelling common myths and fears with evidence-based facts on safety, results and side effects.

While modern dermal fillers have been around for nearly two decades, they've seen a huge bump in popularity in the last few years. And it seems the stigma around facial enhancements like filler and ...

VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...

Cabotegravir and rilpivirine (cabenuva), the only complete HIV treatment regimen delivered by injection, could be given by intramuscular injection to the thigh rather than the gluteal muscles, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...